Clinical trial Recruiting at 1 site Interventional Ages 50 and up

Supplemental Mobility for older adults in skilled nursing facilities

Official title: Improving Functional Recovery in Skilled Nursing Facilities Through Supplemental Mobility

Run by University of Colorado, Denver · NCT07872384 · Data updated 2026-11-12

This pilot tests whether adding a mobility aide to support walking and transfers alongside regular rehab helps older adults in SNFs after hospitalization see more daily activity and safer mobility.

Quick facts

Study typeInterventional
Ages50 Years and up
SexAll
Enrollment192 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations2 sites (Aurora, Colorado and 1 other locations)
StatusRecruiting
StartedOctober 1, 2026
Main results expectedMarch 2028
Study endsMay 2028
Registry record updatedNovember 10, 2026
Trial IDNCT07872384 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 50 years and older admitted to a skilled nursing facility from the hospital, able to ambulate with minimal assistance at admission.

Probably not a fit

Patients who have contraindications to high-intensity resistance training or require greater than minimal assistance for ambulation may not benefit from STAMP.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study will assess the feasibility, acceptability, and safety of the Safe Transfers And Mobility Program (STAMP) when added to standard rehab in skilled nursing facility residents recently discharged from hospital. Participants receive either high-intensity rehabilitation or usual care rehabilitation plus STAMP, delivered by a mobility aide to increase non-therapy activity outside structured sessions. The study also evaluates the variability and practicality of common physical function outcome measures to inform a larger future trial. The aim is to determine whether STAMP can address barriers such as staff shortages and safety concerns to boost daily activity and functional recovery in SNFs. Results will provide preliminary data on program delivery and safety to guide future scale-up.

Why it matters

Potential benefit: If successful, STAMP could help patients achieve more daily activity and better functional recovery after hospital discharge from SNFs.

How similar studies have gone: Previous work suggests that high-intensity rehab alone may be insufficient when patients remain largely inactive outside therapy, supporting the need for additional mobility supports like STAMP.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* At least 50 years old
* Admitted to SNF from the hospital
* Ambulatory at admission with minimal assistance or less

Exclusion Criteria:

* Contraindications to high-intensity resistance training (per American College of Sports Medicine Exercise Testing and Prescription)
* Neurological diagnosis (e.g., cerebral vascular accident, multiple sclerosis, Parkinson's disease, traumatic brain injury)
* Lower extremity weight-bearing precautions that require greater than minimal assistance with ambulation
* Subsequent SNF admission

Where it's running

  • Aegis Therapies
    Frisco, Texas, United States
    Recruiting
  • University of Colorado Denver, Anschutz Medical Campus
    Aurora, Colorado, United States
    Not yet recruiting

Study contacts

  • Principal investigator: Jennifer Stevens-Lapsley, PT, PhD — University of Colorado, Denver

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.